KRAS GENE MUTATION

Clinical trials for KRAS GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new KRAS GENE MUTATION trials appear

Sign up with your email to follow new studies for KRAS GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 3 Terminated 1

New drug cocktail targets Hard-to-Treat cancers

Disease control Terminated

This early-stage trial tests the safety and best dose of the drug neratinib when combined with one of three other drugs (everolimus, palbociclib, or trametinib) in people with advanced solid tumors that have certain gene mutations or amplifications. The study enrolls 93 participa…

Matched conditions: KRAS GENE MUTATION

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jul 24, 2026 00:00 UTC

KRAS GENE MUTATION

Get alerted when new KRAS GENE MUTATION trials appear

New drug cocktail targets Hard-to-Treat cancers